Taurine for prevention of stroke-like episodes in MELAS: an open-label, 4-year phase III trial

Yoshihide Sunada

Presentation information

Oral Session

[O-33] Clinical trial and Regenerative medicine2

Fri. May 24, 2019 9:45 AM - 11:15 AM Room 10 (Osaka International Convention Center 12F Grande Toque)

Chair:Satoshi Kuwabara(Department of Neurology, Graduate school of Medicine, Chiba University) Commentator:Masahiro Nomoto(Saiseikai Imabari, Wefare and Hospital, Director, Neurology)

[O-33-2] Taurine for prevention of stroke-like episodes in MELAS: an open-label, 4-year phase III trial

Yoshihide Sunada¹, Yutaka Ohsawa¹, Mitsue Rikimaru¹, Yuta Fukai¹, Masahiro Fujino², Shin-ichiro Nishimatsu³, Shigeo Ohta⁴ (1.Department of Neurology, Kawasaki Medical School, Japan, 2.Department of Health and Sports Science, Kawasaki University of Medical Welfare, Japan, 3.Department of Natural Science, Kawasaki Medical School, Japan, 4.Department of Neurology, Juntendo University, Japan)

Abstract password authentication.
Password is written on a pocket program and name badge.